177 related articles for article (PubMed ID: 36648741)
1. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
Bharti N; Agrawal V; Kamthan S; Prasad N; Agarwal V
Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741
[TBL] [Abstract][Full Text] [Related]
2. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
4. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
5. Expression and significance of TGF-beta1/Smad signaling pathway in children with IgA nephropathy.
Wu W; Jiang XY; Zhang QL; Mo Y; Sun LZ; Chen SM
World J Pediatr; 2009 Aug; 5(3):211-5. PubMed ID: 19693466
[TBL] [Abstract][Full Text] [Related]
6. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
[TBL] [Abstract][Full Text] [Related]
7. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
Zhang Q; Zhao Y; Luo Y; Guo S; Hou H; Han X; Zhou Y
Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Modified Huangqi Chifeng decoction in alleviating renal fibrosis in rats with IgA nephropathy by inhibiting the TGF-β1/Smad3 signaling pathway through exosome regulation.
Zhao M; Yang B; Li L; Si Y; Chang M; Ma S; Li R; Wang Y; Zhang Y
J Ethnopharmacol; 2022 Mar; 285():114795. PubMed ID: 34737009
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy.
Chen X; Peng S; Zeng H; Fu A; Zhu Q
Indian J Pharmacol; 2015; 47(1):27-33. PubMed ID: 25821307
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
Guan J; Wang M; Zhao M; Ni W; Zhang M
BMC Nephrol; 2023 Mar; 24(1):60. PubMed ID: 36941570
[TBL] [Abstract][Full Text] [Related]
11. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
12. Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy.
Wang F; Xie X; Fan J; Wang L; Guo D; Yang L; Ma X; Zhang L; Li Z
Int Urol Nephrol; 2010 Sep; 42(3):811-9. PubMed ID: 19946746
[TBL] [Abstract][Full Text] [Related]
13. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
15. The Role of Renal Macrophage, AIM, and TGF-β1 Expression in Renal Fibrosis Progression in IgAN Patients.
Yang M; Liu JW; Zhang YT; Wu G
Front Immunol; 2021; 12():646650. PubMed ID: 34194427
[TBL] [Abstract][Full Text] [Related]
16. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy.
Lim CS; Kim YS; Chae DW; Ahn C; Han JS; Kim S; Lee JS; Kim IS
Clin Nephrol; 2005 Feb; 63(2):61-7. PubMed ID: 15730046
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of TGF-β1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation.
Shuiai Z; Huijun S; Weizhong G; Aimin L; Jianhua M
Clinics (Sao Paulo); 2017 Feb; 72(2):95-102. PubMed ID: 28273242
[TBL] [Abstract][Full Text] [Related]
18. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy.
Chihara Y; Ono H; Ishimitsu T; Ono Y; Ishikawa K; Rakugi H; Ogihara T; Matsuoka H
Clin Nephrol; 2006 Jun; 65(6):385-92. PubMed ID: 16792132
[TBL] [Abstract][Full Text] [Related]
19. Mast cells, TGF-beta1 and alpha-SMA expression in IgA nephropathy.
Silva GE; Costa RS; Ravinal RC; dos Reis MA; Dantas M; Coimbra TM
Dis Markers; 2008; 24(3):181-90. PubMed ID: 18334740
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of TGF-β1 in children with primary IgA nephropathy].
Zhu HT; Ru L; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):749-53. PubMed ID: 25008886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
